ADTX News and Press, ADiTx Therapeutics Inc. From 01/18/22

Aditxt meets the timeline imposed by the FDA for laboratory-developed tests (“LDT”s) to request Emergency Use Authorization (“EUA”) by January 14 th AditxtScore™ for COVID-19 will continue to be available during the FDA review A...

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX) announced today it is participating in Edison Group’s Open House Event, scheduled to take place virtually this month. The three-day event, in association with the London Stock Exchange, global...

Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it will host an online business update townhall meeting with Amro Albanna, Co-Founder & CEO on...

NEW YORK, NY / ACCESSWIRE / December 31, 2021 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Aditxt Inc. (NASDAQ:ADTX) and AiPharma Global Holdings LLC is fair to Aditxt shareholders. Halper Sadeh encourages Aditxt shareholders to click her...

Aditxt (NASDAQ:ADTX) jumps 10% pre market as it signs an amendment to its February 3, 2020, exclusive license agreement with Stanford University, extending Aditxt’s exclusive right to license the technology deployed in AditxtScore and securing worldwide exclusivity in all fie...

The amendment expands AditxtScore’s clinical utility for personalizing the selection of the right treatment for individuals and monitoring their response to the treatment Aditxt, Inc. (“Aditxt” or the “Company”) (Nasdaq: ADTX), a biotech in...

Confirming earlier reports, Aditxt (NASDAQ:ADTX) has announced a share exchange agreement to acquire AiPharma Global Holdings, a subsidiary of AiPharma Group. AiPharma owns exclusive rights to Avigan and all formulation of its active pharmaceutical ingredient Favipiravir. These oral antiviral...

If complete, the transaction would be the first step in establishing commercial presence in infectious disease therapeutics and transforming Aditxt into a global biotech company Aditxt Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the ...

3 Penny Stocks For Your Watchlist As the Bull Run Continues With penny stocks and blue chips seeing another bull run today, investors are excited about what the future could hold. Despite fears surrounding the Omicron variant, the Dow managed to jump to near-record highs, up 225 points ...

Aditxt (NASDAQ:ADTX) to acquire a company focused on developing Point-of-Care diagnostics for early detection of diseases including cancers and SARS-CoV-2 through a range of non-invasive and affordable point of care and at-home/in-office test kits. The target holds an exclusive license in ...